Alcoa Inc (NYSE:AA) Director Ratan Tata purchased 1,670 shares of the company’s stock in a transaction that occurred on Friday, April 11th. The shares were purchased at an average price of $12.48 per share, for a total transaction of $20,841.60. Alcoa Inc (NYSE:AA) shares after opening at $13.50 moved to $13.68 on last trade day and at the end of the day closed at $13.56. Company price to sales ratio in past twelve months was calculated as 0.70and price to cash ratio as 23.88. Alcoa Inc (NYSE:AA) showed a positive weekly performance of 6.77%.
Citigroup Inc (NYSE:C) CEO Barbara Desoer bought 1,000 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, April 15th. Citigroup Inc (NYSE:C) shares advanced 0.08% in last trading session and ended the day on $48.22. C return on equity ratio is recorded as 8.50% and its return on assets is 0.90%. Citigroup Inc (NYSE:C) yearly performance is 7.04%.
SVP Daniel P. Witt acquired 10,000 shares of Repligen Corporation (NASDAQ:RGEN) stock on the open market in a transaction dated Tuesday, April 15th. Repligen Corporation (NASDAQ:RGEN) shares moved up 2.86% in last trading session and was closed at $15.84 while trading in range of $15.22 – $16.22 – Repligen Corporation (NASDAQ:RGEN) year to date (YTD) performance is 16.13%.
Inovio Pharmaceuticals Inc (NYSE:INO) CEO Jong Joseph Kim purchased 25,000 shares of the stock in a transaction dated Tuesday, April 15th. The stock was purchased at an average cost of $2.25 per share, for a total transaction of $56,250.00. Inovio Pharmaceuticals Inc (NYSEMKT:INO) weekly performance is -16.00%. On last trading day company shares ended up $2.52. Inovio Pharmaceuticals Inc (NYSEMKT:INO) distance from 50-day simple moving average (SMA50) is -21.44%. Analysts mean target price for the company is $4.60.
Leave a Reply